Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000259591 | SCV000339148 | uncertain significance | not provided | 2016-01-21 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001079023 | SCV001010985 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001526958 | SCV001737731 | likely benign | not specified | 2021-06-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000259591 | SCV001858991 | likely benign | not provided | 2018-10-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002348002 | SCV002649189 | likely benign | Cardiovascular phenotype | 2021-06-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003920099 | SCV004735048 | likely benign | TTN-related condition | 2020-11-02 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |